Fractyl Health(GUTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GUTS Fractyl Health

停牌 10-02 16:00:00 EDT

0.4066

-0.0435

-9.66%

盘后0.4000

-0.0066-1.62%

19:47 EDT

最高0.4496	最低0.4000	成交量305.78万
今开0.4479	昨收0.4501	日振幅11.01%
总市值6,451万	流通市值5,204万	总股本1.59亿
成交额126.86万	换手率2.39%	流通股本1.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GUTS","market":"US","secType":"STK","nameCN":"Fractyl Health","latestPrice":0.4066,"timestamp":1790971200000,"preClose":0.4501,"halted":3,"volume":3057782,"hourTrading":{"tag":"盘后","latestPrice":0.4,"preClose":0.4066,"latestTime":"19:47 EDT","volume":146657,"amount":59234.6419,"timestamp":1790984829403,"change":-0.0066,"changeRate":-0.016232,"amplitude":0.147811},"delay":0,"changeRate":-0.09664518995778712,"floatShares":128000000,"shares":158648963,"eps":-1.1193,"marketStatus":"停牌","change":-0.0435,"latestTime":"10-02 16:00:00 EDT","open":0.4479,"high":0.44955,"low":0.4,"amount":1268630.942852,"amplitude":0.110087,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.1193,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1706850000000,"exchange":"NASDAQ","adjPreClose":0.4501,"preHourTrading":{"tag":"盘前","latestPrice":0.4415,"preClose":0.4501,"latestTime":"09:29 EDT","volume":42871,"amount":18971.18789187,"timestamp":1790947764805,"change":-0.0086,"changeRate":-0.019107,"amplitude":0.062208},"postHourTrading":{"tag":"盘后","latestPrice":0.4,"preClose":0.4066,"latestTime":"19:47 EDT","volume":146657,"amount":59234.6419,"timestamp":1790984829403,"change":-0.0066,"changeRate":-0.016232,"amplitude":0.147811},"volumeRatio":1.0887099846329147},"requestUrl":"/m/hq/s/GUTS","defaultTab":"news","newsList":[{"id":"1116668228","title":"Fractyl Health 将于2026年8月10日披露第二季度财报及业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1116668228","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116668228?lang=zh_cn&edition=full","pubTime":"2026-08-04 04:06","pubTimestamp":1785787612,"startTime":"0","endTime":"0","summary":"Fractyl Health 宣布，计划于2026年8月10日发布其第二季度财务业绩，并同步更新公司业务动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192789379","title":"Fractyl Health：关键六个月REMAIN-1数据预计2026年第四季度初出炉；FDA提交计划定于2026年第四季度末","url":"https://stock-news.laohu8.com/highlight/detail?id=1192789379","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192789379?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:07","pubTimestamp":1784110036,"startTime":"0","endTime":"0","summary":"Fractyl Health公司宣布，其关键性REMAIN-1研究的六个月主要疗效数据预计将在2026年第四季度初获得。紧随其后，公司计划于2026年第四季度末向美国食品药品监督管理局（FDA）提交监管申请。这一时间表标志着该公司在推进其创新疗法方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102280016","title":"Fractyl Health：未报告器械相关严重不良事件，各组间治疗期不良事件发生率相近","url":"https://stock-news.laohu8.com/highlight/detail?id=1102280016","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102280016?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:03","pubTimestamp":1784109826,"startTime":"0","endTime":"0","summary":"Fractyl Health 公布的数据显示，在其相关试验中，未报告与器械相关的严重不良事件。此外，各组间观察到的治疗期不良事件发生率也基本相似。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155921565","title":"Fractyl Health公布REMAIN-1中期队列随机数据：GLP-1停药一年后体重维持效果显著","url":"https://stock-news.laohu8.com/highlight/detail?id=1155921565","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155921565?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:03","pubTimestamp":1784109784,"startTime":"0","endTime":"0","summary":"Fractyl Health公布了其REMAIN-1研究中期队列的积极随机数据。数据显示，在接受该公司疗法后停止使用GLP-1受体激动剂的患者，在停药一年后仍成功维持了减重效果。\n这项数据凸显了该疗法在实现持久体重管理方面的潜力。当前，许多患者在停止使用GLP-1类药物后，体重容易出现反弹。REMAIN-1研究的中期结果为此挑战提供了一个潜在的解决方案。\n研究结果表明，该介入性疗法可能帮助患者长期维持健康体重，即使是在停止使用GLP-1药物之后。这为肥胖症的长期管理开辟了新的可能性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137439656","title":"Fractyl Health公布Reveal-1开放标签研究积极一年期结果：单次Revita®手术后实现GLP-1停药后体重持续维持","url":"https://stock-news.laohu8.com/highlight/detail?id=1137439656","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137439656?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:03","pubTimestamp":1780571015,"startTime":"0","endTime":"0","summary":"Fractyl Health公司报告了其Reveal-1开放标签研究取得的积极一年期结果。数据显示，在接受单次Revita®手术后，患者在停止GLP-1药物治疗后，体重得以持续维持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177113082","title":"Fractyl Health宣布Rejuva临床开发项目资金已到位至2027年初，资本计划维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1177113082","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177113082?lang=zh_cn&edition=full","pubTime":"2026-05-11 19:02","pubTimestamp":1778497350,"startTime":"0","endTime":"0","summary":"Fractyl Health公司宣布，其Rejuva临床开发项目已获得充足资金支持，足以持续至2027年初。公司目前的资本计划保持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100914453","title":"Fractyl Health获准在荷兰启动Rjva-001首次人体试验：首个进入2型糖尿病临床开发阶段的基因疗法候选药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1100914453","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100914453?lang=zh_cn&edition=full","pubTime":"2026-05-11 19:01","pubTimestamp":1778497309,"startTime":"0","endTime":"0","summary":"Fractyl Health已获得授权，将在荷兰启动其候选药物Rjva-001的首次人体临床试验。这标志着该药物成为全球首个进入针对2型糖尿病临床开发阶段的基因疗法候选产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518400504","title":"Fractyl Health, Inc.2024财年实现净利润-68.69百万美元，同比增加10.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518400504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518400504?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449682,"startTime":"0","endTime":"0","summary":"3月9日，Fractyl Health, Inc.公布财报，公告显示公司2024财年净利润为-68.69百万美元，同比增加10.90%；其中营业收入为93000.00美元，同比减少22.50%，每股基本收益为-1.44美元。从资产负债表来看，Fractyl Health, Inc.总负债79.65百万美元，其中短期债务4.96百万美元，资产负债比为0.02，流动比率为3.63。机构评级：截至2025年3月9日，当前有2家机构对Fractyl Health, Inc.目标价做出预测，其中目标均价为8.00美元，其中最低目标价为6.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000252a266b42b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000252a266b42b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517926161","title":"Fractyl Health, Inc.盘中异动 下午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517926161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517926161?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:22","pubTimestamp":1741206128,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时22分，Fractyl Health, Inc.股票出现异动，股价急速上涨5.00%。Fractyl Health, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为973.32%、318.27%、313.68%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为82.59%、54.27%、51.93%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042208abea129d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042208abea129d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516669144","title":"Fractyl Health(GUTS.US)：2024年Q4财报实现营收3000美元，前值为7000美元，预期值为1万美元；每股收益为-0.52美元，前值为-11.18美元，预期值为-0.44美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516669144","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516669144?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:29","pubTimestamp":1741037354,"startTime":"0","endTime":"0","summary":"Fractyl Health(GUTS.US)：2024年Q4财报实现营收3000美元，前值为7000美元，预期值为1万美元；每股收益为-0.52美元，前值为-11.18美元，预期值为-0.44美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04052948499182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126943086","title":"Fractyl Health第四季度GAAP每股收益$(0.52)不及预期$(0.34)，销售额$3.00K不及预期$10.00K","url":"https://stock-news.laohu8.com/highlight/detail?id=1126943086","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126943086?lang=zh_cn&edition=full","pubTime":"2025-03-04 05:20","pubTimestamp":1741036842,"startTime":"0","endTime":"0","summary":"Fractyl Health 公布的季度每股亏损为$，低于分析师普遍预期的$，差异为52.94%。与去年同期$7.00千美元的销售额相比，这一数据下降了57.14%。以上内容来自Benzinga Earnings专栏，原文如下：$Fractyl Health$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 52.94 percent. This is a 95.35 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $3.00 thousand which missed the analyst consensus estimate of $10.00 thousand by 70.00 percent.  This is a 57.14 percent decrea","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Fractyl Health第四季度GAAP每股收益$(0.52)不及预期$(0.34)，销售额$3.00K不及预期$10.00K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516360637","title":"Fractyl Health, Inc.盘中异动 股价大跌5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516360637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516360637?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:50","pubTimestamp":1741013423,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时50分，Fractyl Health, Inc.股票出现波动，股价大幅跳水5.13%。截至发稿，该股报1.48美元/股，成交量2.5566万股，换手率0.05%，振幅10.22%。Fractyl Health, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032250249637b1e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032250249637b1e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514380124","title":"Fractyl Health, Inc.盘中异动 临近午盘急速拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514380124?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:47","pubTimestamp":1740674836,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时47分，Fractyl Health, Inc.股票出现波动，股价急速拉升5.40%。Fractyl Health, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Alpha Tau Medical Ltd C/Wts 、Pepgen Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1691.29%、276.32%、114.71%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Quoin Pharmaceuticals Ltd、Pds Biotechnology Corporation，振幅分别为86.14%、47.79%、45.45%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004717abdf8e99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004717abdf8e99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512743100","title":"Fractyl Health, Inc.盘中异动 临近收盘股价大跌5.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512743100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512743100?lang=zh_cn&edition=full","pubTime":"2025-02-20 05:02","pubTimestamp":1739998935,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日05时02分，Fractyl Health, Inc.股票出现波动，股价急速下跌5.23%。截至发稿，该股报1.45美元/股，成交量24.9485万股，换手率0.52%，振幅6.89%。Fractyl Health, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220050215a24c405b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220050215a24c405b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GUTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511611708","title":"Fractyl Health, Inc.盘中异动 下午盘急速下跌5.42%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511611708","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511611708?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:39","pubTimestamp":1739561949,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时39分，Fractyl Health, Inc.股票出现波动，股价急速下挫5.42%。截至发稿，该股报1.57美元/股，成交量14.583万股，换手率0.30%，振幅7.23%。Fractyl Health, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021503391096235f6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021503391096235f6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GUTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511218405","title":"Fractyl Health, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511218405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511218405?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:17","pubTimestamp":1739459867,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时17分，Fractyl Health, Inc.股票出现波动，股价急速拉升5.41%。Fractyl Health, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Edesa Biotech, Inc.、Nutriband Inc C/Wts 、Enanta Pharmaceuticals, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1911.52%、1124.41%、147.85%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为92.30%、73.65%、40.29%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132317479884358b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132317479884358b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510872380","title":"Fractyl Health, Inc.盘中异动 早盘急速下挫5.37%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510872380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510872380?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:35","pubTimestamp":1739284555,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时35分，Fractyl Health, Inc.股票出现异动，股价大幅下挫5.37%。Fractyl Health, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为2087.95%、546.87%、182.40%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为25.06%、22.23%、18.18%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235569881bdc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235569881bdc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509775356","title":"Fractyl Health, Inc.盘中异动 下午盘快速跳水5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509775356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509775356?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:01","pubTimestamp":1738958473,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时01分，Fractyl Health, Inc.股票出现异动，股价大幅跳水5.28%。Fractyl Health, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Sionna Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为8679.21%、182.89%、148.94%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、56.78%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040113961b6f88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040113961b6f88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GUTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509280730","title":"Fractyl Health, Inc.盘中异动 大幅上涨5.22%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280730","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509280730?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:08","pubTimestamp":1738768113,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时08分，Fractyl Health, Inc.股票出现波动，股价大幅拉升5.22%。截至发稿，该股报1.62美元/股，成交量7.3161万股，换手率0.15%，振幅5.90%。Fractyl Health, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230833987b82bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205230833987b82bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GUTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509464122","title":"Fractyl Health, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509464122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509464122?lang=zh_cn&edition=full","pubTime":"2025-02-05 01:07","pubTimestamp":1738688843,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日01时07分，Fractyl Health, Inc.股票出现波动，股价急速下跌5.00%。Fractyl Health, Inc.股票所在的生物技术行业中，整体涨幅为1.53%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1735.71%、945.64%、558.27%，振幅较大的相关个股有Azitra Inc、Cingulate Inc C/Wts 10/12/2026 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为72.82%、57.14%、49.88%。Fractyl Health, Inc.公司简介：Fractyl Health Inc 是一家代谢治疗公司，专注于开发治疗代谢疾病的新方法，包括2型糖尿病和肥胖症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205010723a23946a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205010723a23946a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","GUTS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.fractyl.com","stockEarnings":[{"period":"1week","weight":-0.1627},{"period":"1month","weight":-0.4246},{"period":"3month","weight":-0.4664},{"period":"6month","weight":-0.1081},{"period":"1year","weight":-0.741},{"period":"ytd","weight":-0.8152}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fractyl Health, Inc.于2010年8月30日在特拉华州注册成立。该公司是一家临床阶段的代谢疗法公司，专注于开发治疗肥胖和2型糖尿病的新方法。其主要候选产品Revita DMR系统旨在重塑十二指肠黏膜，以解决代谢疾病的根本原因。","exchange":"NASDAQ","name":"Fractyl Health","nameEN":"Fractyl Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fractyl Health(GUTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fractyl Health(GUTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fractyl Health,GUTS,Fractyl Health股票,Fractyl Health股票老虎,Fractyl Health股票老虎国际,Fractyl Health行情,Fractyl Health股票行情,Fractyl Health股价,Fractyl Health股市,Fractyl Health股票价格,Fractyl Health股票交易,Fractyl Health股票购买,Fractyl Health股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fractyl Health(GUTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fractyl Health(GUTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}